Feature

For Radiation ‘Downwinders,’ Cancer Compensation Is On Hold


 

As Compensation Is On Hold, Medical Screening Continues

A major benefit is still available for downwinders and uranium workers: Free medical screening and referrals for medical treatment. The Radiation Exposure Screening and Education Program’s funding has not been affected by the congressional impasse, so screenings are continuing for eligible people exposed to radiation.

Radiation exposure clinics offer screening in Arizona, Colorado, Nevada, New Mexico, and Utah, and health providers can get funding to offer screening in other affected states.

In Nevada, “we hold screening clinics throughout the state: Caliente, Ely, and Winnemucca. Also, in Reno and Las Vegas, which are not in designated downwind areas, but many downwinders have migrated there,” said Shaw in an interview. Among downwinders, “our youngest patients are in their 60s and range up to a few in their 90s,” she said.

Patients fill out questionnaires that ask about their medical problems, family history, and medications. “Ely patients in particular seem to have extensive family histories of cancer, and this may be due to their location directly downwind of the Nevada Test Site,” Shaw said. (Ely is a remote town in central eastern Nevada near the Utah border.)

The screenings cover both cancer and noncancer conditions. Shaw said clinicians often diagnose problems other than the covered cancers — new cases of atrial fibrillation, diabetes, and hypertension. “We see a ton of prostate and skin cancer” but don’t make patients eligible for the compensation program because they’re not covered, she said.

Even as compensation is on hold, doctors can get the word out that screenings are still available, Shaw said. “We continue to get contacted by individuals who in these communities who have never heard of this program, even though we’ve been holding clinics since 2005,” Shaw said. “Despite outreach activities and advertising through newspapers and radio, we find the most successful method of reaching these patients is through word of mouth — either from other patients or their doctors. That is why we feel it is so important to reach other physicians as well.”

Affected Patients Don’t Just Live in the West

On the outreach front, clinicians in states outside of the western US region can be helpful, too. Shaw urged oncologists nationwide to ask older patients where they lived in the 1950s and 1960s. “Did they live in Nevada, Arizona, Utah, and other Western states that are downwind? They may qualify for needed services and future compensation.”

With regard to compensation, she noted that applicants need to prove that they lived in affected areas many decades ago. And, of course, they must prove that they’ve had cancer. Locating residency records “has often been an enormous challenge.” Old utility bills, pay stubs, and high school annuals can be helpful, “but these records tend to disappear. People and their families throw stuff away.”

Even proving a cancer diagnosis can be a challenge because records can be missing. In Nevada, the law says clinicians only need to keep medical records for 5 years, Shaw said. “Imaging and pathology reports are destroyed. Patients that have been diagnosed with cancer can’t prove it.”

Shaw said she hopes oncologists will offer these messages to patients: “Be an advocate for your own health and keep copies of your own records. Discuss your diagnosis with your family and contact a cancer registry if you are diagnosed with cancer.”

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Fear of Cancer Recurrence Can Persist for Childhood Survivors
MDedge Hematology and Oncology
The New Cancer Stats Might Look Like a Death Sentence. They Aren’t.
MDedge Hematology and Oncology
Is BMI Underestimating Breast Cancer Risk in Postmenopausal Women?
MDedge Hematology and Oncology
SBRT or Prostatectomy for Localized Prostate Cancer: Is One Better?
MDedge Hematology and Oncology
Risk Assessment Tool Can Help Predict Fractures in Cancer
MDedge Hematology and Oncology
Is It Possible To Treat Patients You Dislike?
MDedge Hematology and Oncology
Adjuvant Chemo Beneficial in TNBC With High Immune Infiltration
MDedge Hematology and Oncology
Gotistobart Trial for NSCLC on Partial Clinical Hold
MDedge Hematology and Oncology
Cannabis in Cancer: What Oncologists and Patients Should Know
MDedge Hematology and Oncology
Should First-Line Dual Checkpoint Blockade Be Used for NSCLC With Specific Mutations?
MDedge Hematology and Oncology